Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Charles River Microbial Solutions
Charles River Microbial Solutions
Activities:
Analysis
X
LinkedIn
Trending Articles
Neopac showcases latest tube, dispensing and cap innovations at Pharmapack Paris
Highlights include company’s reduced material LowPro caps and world’s smallest child resistant tube
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
You need to be a subscriber to read this article.
Click here
to find out more.
Parenteral preparations: formulation challenges
Parenteral preparations are defined as solutions, suspensions, emulsions for injection or infusion, powders for injection or infusion, gels for injection and implants. They are...
Lonza’s capsule delivers acid-sensitive ingredients to the intestine
The capsule can simplify the manufacturing process to accelerate drug development and expedite first-in-human timelines
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Research & Development
Charles River launches Rep/Cap plasmids to streamline adeno-associated viral vector manufacturing
Off-the-shelf Rep/Cap simplifies gene therapy supply chains with immediate availability
Research & Development
CELLphenomics and Charles River to expand 3D in vitro services for cancer therapy drug screening
CELLphenomics’ PD3D tumour model platform will expand Charles River’s portfolio of 3D in vitro testing services
Manufacturing
Multiply Labs' robotic pharmaceutical manufacturing project reaches proof-of-concept
The consortium which contains Multiply Labs, Thermo Fisher, Cytiva, UCSF and Charles River has reached proof-of-concept on a robotic and automated cell manufacturing system
Manufacturing
Charles River announces plasmid manufacturing collaboration with Fondazione Telethon
The two companies have agreed on a manufacturing collaboration that will produce pDNA, used to produce GMP lentivirus for ex vivo gene therapy
Manufacturing
Wheeler Bio welcomes Charles River's biologics lab at manufacturing facility
Deployed on-site at a client’s facility, Charles River helps implement a flexible biologics testing lab
Manufacturing
Charles River and Cure AP-4 collaborate on gene therapy
The company is set to perform HQ plasmid production in support of Phase I/II clinical trials for AP-4 Hereditary Spastic Paraplegia
Manufacturing
Charles River opens plasmid DNA centre of excellence
The expansion follows Charles River's acquisition of Cognate BioServices and Cobra Biologics, a pioneering plasmid DNA, viral vector, and cell therapy CDMO in March 2021
Subscribe now